- Home
- SGML vs BLFS Comparison
SGML vs BLFS Comparison
Compare SGML & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SGML | BLFS |
|---|---|---|
| Founded | 2011 | 1987 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | N/A | 1989 |
Fundamental Metrics
Financial Performance| Metric | SGML | BLFS |
|---|---|---|
| Price | $11.19 | $24.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $13.00 | ★ $31.50 |
| AVG Volume (30 Days) | ★ 9.7M | 349.1K |
| Earning Date | 11-14-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $138,959,151.00 | $100,144,000.00 |
| Revenue This Year | $52.45 | $20.67 |
| Revenue Next Year | $22.13 | $14.13 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 87.53 |
| 52 Week Low | $4.25 | $19.10 |
| 52 Week High | $13.40 | $29.62 |
Technical Indicators
Market Signals| Indicator | SGML | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 61.22 | 39.63 |
| Support Level | $9.37 | $24.44 |
| Resistance Level | $12.36 | $25.96 |
| Average True Range (ATR) | 1.24 | 0.87 |
| MACD | 0.04 | -0.08 |
| Stochastic Oscillator | 63.15 | 4.36 |
Price Performance
Historical ComparisonAbout SGML Sigma Lithium Corporation
Sigma Lithium Corp together with its direct and indirect subsidiaries, is a commercial producer of lithium concentrate. It holds a 100% interest in four mineral properties: Grota do Cirilo, Sao Jose, Santa Clara, and Genipapo, located in the municipalities of Aracuai and Itinga, in the Vale do Jequitinhonha region in the State of Minas Gerais, Brazil.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.